Description
AMARYL® XM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus:
– That are not adequately controlled with monotherapy with glimepiride alone or with metformin alone.
– Requiring a replacement of dose-independent combination therapy with glimepiride and metformin.
AMARYL XM GLIMEPIRIDE-METFORMIN 4/850MG 16TABS ER
Reviews
There are no reviews yet.